Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Bursitis, Magnetic resonance imaging, Rotator cuff syndrome, SARS-CoV-2 test
Clinical narrative: 3 weeks after receiving the 3rd dose, I began having severe pain in both my shoulders that were never like that before; Both shoulders and have severe tendinitis and bursitis; Both shoulders and have severe tendinitis and bursitis; I did have redness around injection site and area was itchy for 4 days; I did have redness around injection site and area was itchy for 4 days; This is a spontaneous report from a contactable reporter (nurse). The reporter is the patient.  A 59-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 05Nov2021 at 09:00 (Lot number: 32030BD) at the age of 59 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Penicillin allergy" (unspecified if ongoing), notes: Known allergies: Penicillin. There were no concomitant medications. Past drug history included: Fentanyl, reaction: "Drug allergy", notes: Known allergies: Fentanyl and Morphine, reaction: "Drug allergy", notes: Known allergies: Morphine. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE; Lot Number: EL8982; Anatomical Location: Left arm; Administration time: 13:30), administration date: 04Feb2021, when the patient was 58 years old, for COVID-19 immunisation and Bnt162b2 (DOSE 2, SINGLE; Lot Number: EL9264; Anatomical Location: Left arm; Administration time: 10:30), administration date: 25Feb2021, when the patient was 58 years old, for COVID-19 immunisation.  The following information was reported: ARTHRALGIA (non-serious) with onset 24Nov2021 at 10:00, outcome "not recovered", described as "3 weeks after receiving the 3rd dose, I began having severe pain in both my shoulders that were never like that before"; ROTATOR CUFF SYNDROME (non-serious), BURSITIS (non-serious) all with onset 24Nov2021 at 10:00, outcome "not recovered", and all described as "Both shoulders and have severe tendinitis and bursitis"; VACCINATION SITE ERYTHEMA (non-serious), VACCINATION SITE PRURITUS (non-serious) all with onset 24Nov2021 at 10:00, outcome "not recovered", and all described as "I did have redness around injection site and area was itchy for 4 days". The events "3 weeks after receiving the 3rd dose, I began having severe pain in both my shoulders that were never like that before", "Both shoulders and have severe tendinitis and bursitis" and "I did have redness around injection site and area was itchy for 4 days" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthralgia, rotator cuff syndrome and bursitis.  Additional information: Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient had magnetic resonance imaging (MRI) of both shoulders as had severe tendinitis and bursitis in both and it continued until 13Feb2022 (at the time of this report) and physical therapy (PT) was barely helping so far. The patient had redness around injection site and area was itchy for 4 days after the 3rd dose, which she also had a picture of. Treatment for the events arthralgia, rotator cuff syndrome and bursitis included MRI and was receiving PT (at the time of this report). Since the vaccination, the patient had been tested for COVID-19.